163 related articles for article (PubMed ID: 29348788)
41. Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
Li C; Wu H; Wang S; Zhu J
Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
[TBL] [Abstract][Full Text] [Related]
42. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
[TBL] [Abstract][Full Text] [Related]
43. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Narui K; Ishikawa T; Satake T; Adachi S; Yamada A; Shimada K; Shimizu D; Kida K; Sugae S; Ichikawa Y; Tanabe M; Sasaki T; Endo I
Eur J Surg Oncol; 2015 Jan; 41(1):94-9. PubMed ID: 25245538
[TBL] [Abstract][Full Text] [Related]
45. Breast Cancer: Influence of Taxanes on Response Assessment with Dynamic Contrast-enhanced MR Imaging.
Schrading S; Kuhl CK
Radiology; 2015 Dec; 277(3):687-96. PubMed ID: 26176656
[TBL] [Abstract][Full Text] [Related]
46. [Neoadjuvant (preoperative) chemotherapy for resectable breast cancer].
Kobayashi T; Kuraishi Y; Uchida K; Sakurai K
Gan To Kagaku Ryoho; 1994 Mar; 21(4):440-51. PubMed ID: 8129384
[TBL] [Abstract][Full Text] [Related]
47. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.
Gu X; Xue JQ; Han SJ; Qian SY; Zhang WH
Cancer Biomark; 2016; 16(3):395-403. PubMed ID: 27062696
[TBL] [Abstract][Full Text] [Related]
48. Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.
Hage AN; Capriccioso C; Brennan J; Heiden B; Zheutlin A; Sabel MS
J Surg Oncol; 2017 Nov; 116(6):665-670. PubMed ID: 28672101
[TBL] [Abstract][Full Text] [Related]
49. Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.
Barrou J; Bannier M; Cohen M; Lambaudie E; Gonçalves A; Bertrand P; Buttarelli M; Opinel P; Sterkers N; Tallet A; Zinzindohoué C; Houvenaeghel G
Breast; 2017 Apr; 32():37-43. PubMed ID: 28033508
[TBL] [Abstract][Full Text] [Related]
50. Alteration in steroid hormone and Her-2/neu receptor status following neoadjuvant chemotherapy in locally advanced breast cancer: Experience at a tertiary care centre in India.
Ramteke P; Seenu V; Prashad R; Gupta SD; Iyer V; Deo S; Gogia A; Mathur S
Indian J Cancer; 2016; 53(3):366-371. PubMed ID: 28244460
[TBL] [Abstract][Full Text] [Related]
51. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
[TBL] [Abstract][Full Text] [Related]
52. Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.
Hennigs A; Riedel F; Marmé F; Sinn P; Lindel K; Gondos A; Smetanay K; Golatta M; Sohn C; Schuetz F; Heil J; Schneeweiss A
Breast Cancer Res Treat; 2016 Dec; 160(3):491-499. PubMed ID: 27744486
[TBL] [Abstract][Full Text] [Related]
53. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).
Danishad KK; Sharma U; Sah RG; Seenu V; Parshad R; Jagannathan NR
NMR Biomed; 2010 Apr; 23(3):233-41. PubMed ID: 20175134
[TBL] [Abstract][Full Text] [Related]
54. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
[TBL] [Abstract][Full Text] [Related]
55. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis.
Miglietta L; Vanella P; Canobbio L; Naso C; Cerisola N; Meszaros P; Parodi MA; Morabito F
Oncology; 2010; 79(3-4):255-61. PubMed ID: 21372600
[TBL] [Abstract][Full Text] [Related]
57. Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer.
Baba M; Takahashi M; Yamashiro K; Yokoo H; Fukai M; Sato M; Hosoda M; Kamiyama T; Taketomi A; Yamashita H
Surg Today; 2016 Jul; 46(7):843-51. PubMed ID: 26494004
[TBL] [Abstract][Full Text] [Related]
58. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
[TBL] [Abstract][Full Text] [Related]
59. The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.
Storr SJ; Zhang S; Perren T; Lansdown M; Fatayer H; Sharma N; Gahlaut R; Shaaban A; Martin SG
Oncotarget; 2016 Jul; 7(30):47927-47937. PubMed ID: 27323818
[TBL] [Abstract][Full Text] [Related]
60. Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer.
Kneubil MC; Goulart KOB; Brollo J; Coelho GP; Mandelli J; Orlandin BC; Corso LL; Roesch-Ely M; Henriques JAP
Braz J Med Biol Res; 2022; 55():e11857. PubMed ID: 35293552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
